Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (141-150 of 492) with videos related to

Pageof 50
Sort By:
Seminars in Arthritis and Rheumatism|August 15, 2015
A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damageChristophe Meune, Dinesh Khanna, Jamil Aboulhosn, et al.
Clinical and Experimental Rheumatology|May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 IndexJérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Joint Bone Spine|January 12, 2016
Small, medium but not large arteries are involved in digital ulcers associated with systemic sclerosisLinda Aïssou, Christophe Meune, Jérôme Avouac, et al.
Seminars in Arthritis and Rheumatism|May 20, 2017
Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls"Sophie I Mavrogeni, Juerg Schwitter, Luna Gargani, et al.
The Journal of Rheumatology|December 3, 2014
Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposureEugénie Koumakis, Jérôme Avouac, Renaud Winzenrieth, et al.
Current Rheumatology Reviews|August 3, 2010
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study DesignDinesh Khanna, James R Seibold, Athol Wells, et al.
Arthritis Research & Therapy|November 6, 2009
Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyAriane Leboime, Jean-Marie Berthelot, Yannick Allanore, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Plos One|May 9, 2020
Improving risk-stratification of rheumatoid arthritis patients for interstitial lung diseaseJérôme Avouac, Anne Cauvet, Alexia Steelandt, et al.
Annals of the Rheumatic Diseases|June 30, 2016
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohortYannick Allanore, Christopher P Denton, Thomas Krieg, et al.
Pageof 50

Showing results (141-150 of 492) with videos related to

Sort By:
Pageof 50
Seminars in Arthritis and Rheumatism|August 15, 2015
A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damageChristophe Meune, Dinesh Khanna, Jamil Aboulhosn, et al.
Clinical and Experimental Rheumatology|May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 IndexJérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Joint Bone Spine|January 12, 2016
Small, medium but not large arteries are involved in digital ulcers associated with systemic sclerosisLinda Aïssou, Christophe Meune, Jérôme Avouac, et al.
Seminars in Arthritis and Rheumatism|May 20, 2017
Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls"Sophie I Mavrogeni, Juerg Schwitter, Luna Gargani, et al.
The Journal of Rheumatology|December 3, 2014
Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposureEugénie Koumakis, Jérôme Avouac, Renaud Winzenrieth, et al.
Current Rheumatology Reviews|August 3, 2010
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study DesignDinesh Khanna, James R Seibold, Athol Wells, et al.
Arthritis Research & Therapy|November 6, 2009
Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyAriane Leboime, Jean-Marie Berthelot, Yannick Allanore, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Plos One|May 9, 2020
Improving risk-stratification of rheumatoid arthritis patients for interstitial lung diseaseJérôme Avouac, Anne Cauvet, Alexia Steelandt, et al.
Annals of the Rheumatic Diseases|June 30, 2016
Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohortYannick Allanore, Christopher P Denton, Thomas Krieg, et al.
Pageof 50